HK1200355A1 - Treatment of red blood cells - Google Patents

Treatment of red blood cells Download PDF

Info

Publication number
HK1200355A1
HK1200355A1 HK15101021.4A HK15101021A HK1200355A1 HK 1200355 A1 HK1200355 A1 HK 1200355A1 HK 15101021 A HK15101021 A HK 15101021A HK 1200355 A1 HK1200355 A1 HK 1200355A1
Authority
HK
Hong Kong
Prior art keywords
red blood
blood cells
treatment
nitric oxide
cell sample
Prior art date
Application number
HK15101021.4A
Other languages
English (en)
Chinese (zh)
Inventor
Warren M. Zapol
Binglan Yu
Original Assignee
通用医疗公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 通用医疗公司 filed Critical 通用医疗公司
Publication of HK1200355A1 publication Critical patent/HK1200355A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0281—Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0429—Red blood cells; Erythrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK15101021.4A 2011-11-07 2012-11-06 Treatment of red blood cells HK1200355A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161556661P 2011-11-07 2011-11-07
US61/556661 2011-11-07
PCT/US2012/063690 WO2013070592A1 (en) 2011-11-07 2012-11-06 Treatment of red blood cells

Publications (1)

Publication Number Publication Date
HK1200355A1 true HK1200355A1 (en) 2015-08-07

Family

ID=48290479

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101021.4A HK1200355A1 (en) 2011-11-07 2012-11-06 Treatment of red blood cells

Country Status (6)

Country Link
US (1) US9572833B2 (enExample)
EP (1) EP2776047A4 (enExample)
JP (1) JP6389125B2 (enExample)
CN (1) CN104159591A (enExample)
HK (1) HK1200355A1 (enExample)
WO (1) WO2013070592A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12529737B2 (en) * 2019-03-25 2026-01-20 Ronald Day Systems and methods for using improved contrast agent in performing and MRI
WO2021015235A1 (ja) * 2019-07-22 2021-01-28 学校法人北里研究所 透析装置
CN111919835B (zh) * 2020-08-06 2022-02-08 温州医科大学 维持红细胞活性的保存液
EP4123303A1 (en) * 2021-07-20 2023-01-25 German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH Non-invasive method for predicting the hemoglobin and iron content in prbc units
EP4633693A1 (en) 2022-12-16 2025-10-22 Fresenius Medical Care Holdings, Inc. Systems and methods for using nitric oxide in dialysis
WO2025212681A1 (en) * 2024-04-01 2025-10-09 Ohio State Innovation Foundation Compositions, kits, and methods for the preservation of blood products

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
DE69127756T2 (de) 1990-12-05 1998-02-05 The General Hospital Corp., Charlestown, Mass. Verwendung von no zur behandlung oder prävention der bronchokonstriktion
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5536241A (en) 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5296466A (en) 1992-02-19 1994-03-22 Board Of Regents, The University Of Texas System Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
US5423738A (en) * 1992-03-13 1995-06-13 Robinson; Thomas C. Blood pumping and processing system
DE59409834D1 (de) 1993-04-17 2001-09-27 Messer Griesheim Austria Ges M Gerät zur kontrollierten Zudosierung von NO zur Atemluft von Patienten
TW381022B (en) 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
GB9320978D0 (en) 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
SE9303486L (sv) 1993-10-22 1995-04-23 Siemens Elema Ab Metod vid bestämning av den funktionella residualkapaciteten för lungor samt en ventilatoranordning för bestämning av den funktionella residualkapaciteten
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
SE503876C2 (sv) 1994-11-30 1996-09-23 Kjell Alving Detektion av inflammatoriska tillstånd i tarmkanalen genom att mäta kväveoxidhalten i ett prov taget ur tarmlumen
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
US6627738B2 (en) * 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
JP2000510448A (ja) * 1996-04-05 2000-08-15 ザ ジェネラル ホスピタル コーポレーション 異常ヘモグロビン症の治療
WO1998008500A1 (en) 1996-08-26 1998-03-05 Board Of Regents, The University Of Texas System Hypertonic arginine compositions and methods
CA2278784A1 (en) * 1997-02-06 1998-08-13 Jonathan S. Stamler No-modified hemoglobins and uses therefor
WO1998050430A2 (en) * 1997-05-02 1998-11-12 Somatogen, Inc. Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
US5900402A (en) 1997-05-29 1999-05-04 Enzon, Inc. Method of reducing side effects associated with administration of oxygen-carrying proteins
US6087087A (en) * 1997-07-03 2000-07-11 Takashi Yonetani Treatment of hemoglobin with nitric oxide
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
US6089229A (en) 1998-05-26 2000-07-18 Datex-Ohmeda, Inc. High concentration no pulse delivery device
US6139506A (en) 1999-01-29 2000-10-31 Instrumentarium Oy Method for measuring pulmonary functional residual capacity
IL147112A0 (en) * 1999-06-14 2002-08-14 Ford Henry Health System Nitric oxide donors for inducing neurogenesis
EP1204870B1 (en) * 1999-08-02 2010-01-20 Duke University Method for determining physiological effects of hemoglobin
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
US7516742B2 (en) 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
US6811778B2 (en) 2001-09-10 2004-11-02 Biopure Corporation Method for improving oxygen transport by stored red blood cells
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
AU2003210952A1 (en) * 2002-02-08 2003-09-02 Gambro, Inc. Nitric oxide in a pathogen inactivation process
EP1514103A4 (en) * 2002-05-29 2006-05-24 Univ Duke MEASUREMENT OF NITROGEN MONOXIDE IN HEMOTOXIC GASES, AND TREATMENT BASED ON THIS MEASURE
WO2005004884A2 (en) 2003-07-09 2005-01-20 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
WO2005025511A2 (en) 2003-09-10 2005-03-24 Cedars-Sinai Medical Center Potassium channel mediated delivery of agents through the blood-brain barrier
US7485324B2 (en) * 2003-09-29 2009-02-03 Pulmonox Technologies Corporation Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
WO2005077005A2 (en) 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
US20050234030A1 (en) 2004-04-20 2005-10-20 Wilmin Bartolini Modulators of CRTH2, COX-2 and FAAH
US7362274B1 (en) 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
EP1799210A1 (en) 2004-10-05 2007-06-27 Bayer HealthCare AG A guanylate cyclase stimulator and nitric oxide for treating bronchoconstriction and pulmonary vasconstriction
US7530353B2 (en) 2005-09-21 2009-05-12 The General Electric Company Apparatus and method for determining and displaying functional residual capacity data and related parameters of ventilated patients
WO2007076318A2 (en) 2005-12-21 2007-07-05 Smithkline Beecham Corporation Camphor-derived cxcr3 antagonists
KR20090087900A (ko) * 2006-11-07 2009-08-18 더 제너럴 하스피탈 코포레이션 혈관작용성 산소운반체에 의해 유도되는 혈관수축의 감소
WO2009038796A1 (en) * 2007-09-20 2009-03-26 Wake Forest University Health Sciences Methods of treatment for hemolysis
DK3266463T3 (da) * 2009-06-09 2024-01-08 Prolong Pharmaceuticals Llc Hæmoglobinsammensætninger

Also Published As

Publication number Publication date
EP2776047A1 (en) 2014-09-17
JP2014532764A (ja) 2014-12-08
US20140286921A1 (en) 2014-09-25
WO2013070592A1 (en) 2013-05-16
JP6389125B2 (ja) 2018-09-12
CN104159591A (zh) 2014-11-19
EP2776047A4 (en) 2015-07-22
US9572833B2 (en) 2017-02-21

Similar Documents

Publication Publication Date Title
WO2009100137A3 (en) Magnetic cells for localizing delivery and tissue repair
WO2012081898A3 (ko) 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
MX387855B (es) Soluciones de dipolo magnètico estabilizado y su uso en el tratamiento de enfermedades, y en el mejoramiento del desempeño.
WO2014004993A3 (en) Methods of reducing ldl-p
NZ778131A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
HK1200322A1 (en) Immunobinders directed against sclerostin
WO2012009678A8 (en) Therapeutically active compositions and their method of use
WO2013180834A3 (en) Compositions and methods of inhibiting masp-1, masp-2 and/or masp-3 for treatment of paroxysmal nocturnal hemoglobinuria
BR112012031163A2 (pt) métodos de terapia combinada para tratamento de doenças proliferativas
EP4582090A3 (en) Composition comprising pegylated arginine deiminase
BR112012012476A2 (pt) "composições nutritivas incluindo um componente de alta proteína e nucleotídeos exôgenos"
MX354743B (es) Anticuerpos monoclonales optimizados contra el inhibidor de la via del factor tisular (tfpi).
HK1210962A1 (en) Methods for treatment of atherosclerosis
WO2011109262A3 (en) Cancer diagnosis and imaging
AU2016219603A1 (en) Method of treating the effects of stroke
WO2010049438A3 (en) Improved methods of using phosphoantigens for the treatment of diseases
WO2012067437A3 (ko) 간 절제를 위한 간 부피 증가용 조성물
MX2014005895A (es) Medicamento para tratamiento terapeutico y/o mejoramiento de sepsis.
WO2014004809A3 (en) Therapy and method for intratumorally introducing cytotoxic t lymphocyte and/or nkt cell with anti-tnf and/or anti-il-10
UA104741C2 (uk) Моноклональні антитіла проти феропортину 1 та варіанти їх застосування
WO2013106766A3 (en) THERAPEUTIC INDICATIONS OF miR-1291
AU2016204146A1 (en) Methods of Increasing Neuronal Differentiation Using Antibodies to Lysophoshatidic Acid
WO2012018866A3 (en) Methods and compositions for the diagnosis and treatment of breast cancer
WO2011031890A3 (en) Cancer stem cell-targeted and drug resistant cancer therapy
WO2009155070A3 (en) Compositions and methods for treatment of inflammation and hyperkeratotic lesions